EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison

Kristen Johnson, Barbara Stoffel, Michael Schwitter, Stefanie Hayoz, Alfonso Rojas Mora, Angela Fischer Maranta, Tämer El Saadany, Ursula Hasler, Roger von Moos, Annalea Patzen, Michael Mark, Gillian Roberts und 1 weitere

Supportive Care in Cancer · 2024-08 · 32 (8)

DOI: 10.1007/s00520-024-08737-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Supportive Care in Cancer, online erschienen am 27.07.2024. Verfasst von Kristen Johnson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland. Hauptthemen laut MEDLINE: Peripheral Nervous System Diseases, Docetaxel, Paclitaxel, Nail Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zurich.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Common side effects of taxane chemotherapy are nail toxicity and peripheral neuropathy (CIPN) causing severe impact on the quality of life. Different methods of cryotherapy to prevent these side effects have been tested. We investigated the use of machine-controlled cooling of hands and feet to reduce nail toxicity and CIPN in patients receiving taxane chemotherapy.

Methods

Patients receiving Docetaxel (planned dose $$\ge$$ ≥ 300 mg/m 2 ) or Paclitaxel (planned dose $$\ge$$ ≥ 720 mg/m 2 $$-$$ - ) in the adjuvant or palliative setting of different cancers were included. The dominant hand and foot were cooled to approximately 10 °C using the Hilotherapy machine. The contralateral hand and foot were used as intrapatient comparison. The primary endpoint was the occurrence of any CIPN due to paclitaxel or nail toxicity due to Docetaxel. Both the intention to treat population (ITT) and the per protocol population (PPP) were analyzed.

Results

A total of 69 patients, 21 treated with Docetaxel and 48 with Paclitaxel, were included at our centre between 08/2020 and 08/2022. Nail toxicity due to Docetaxel was overall not significantly improved by cooling in the ITT or PPP but a significant benefit across visits was found for the ITT. CIPN due to Paclitaxel was numerically better in the ITT and significantly better in the PPP. A significant benefit of cooling on CIPN occurrence across visits was found for the ITT and the PPP. Cooling was very well tolerated.

Conclusion

Cooling of hands and feet has a clinically meaningful impact on reducing occurrence of CIPN and nail toxicity on treatment with taxanes. Effects are more significant over time and are dose dependent. Trial registration number. 2020–00381. Date of registration. 24th February 2020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Nervous System DiseasesDocetaxelPaclitaxelNail DiseasesHumansFemaleProspective StudiesMiddle AgedMaleAgedNeoplasmsAdultTaxoidsAntineoplastic AgentsCryotherapyQuality of Life

Stichwörter der Autor:innen

Chemotherapy-induced polyneuropathy (CIPN)DocetaxelHilotherapyNail changesPaclitaxel

Substanzen

DocetaxelPaclitaxelTaxoidsAntineoplastic Agents

Autor:innen und Institutionen

  • Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland.
  • Department of Internal Medicine, Kantonsspital Graubünden, Chur, Switzerland.
  • SAKK Competence Center, Bern, Switzerland.
  • Division of Oncology/Hematology, Kantonsspital Graubünden, Chur, Switzerland. richard.cathomas@ksgr.ch.
  • University of Zürich, Zurich, Switzerland. richard.cathomas@ksgr.ch.

Förderung

  • University of Zurich

Zitieren

APA

Johnson, K., Stoffel, B., Schwitter, M., Hayoz, S., Rojas Mora, A., Fischer Maranta, A., El Saadany, T., Hasler, U., von Moos, R., Patzen, A., Mark, M., Roberts, G., & Cathomas, R. (2024). Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison. Supportive Care in Cancer, 32(8). https://doi.org/10.1007/s00520-024-08737-3

Vancouver

Johnson K, Stoffel B, Schwitter M, Hayoz S, Rojas Mora A, Fischer Maranta A, et al. Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison. Supportive Care in Cancer. 2024;32(8). doi:10.1007/s00520-024-08737-3

BibTeX
@article{Johnson2024,
  author = {Johnson, Kristen and Stoffel, Barbara and Schwitter, Michael and Hayoz, Stefanie and Rojas Mora, Alfonso and Fischer Maranta, Angela and El Saadany, Tämer and Hasler, Ursula and von Moos, Roger and Patzen, Annalea and Mark, Michael and Roberts, Gillian and Cathomas, Richard},
  title = {Prevention of taxane chemotherapy-induced nail changes and peripheral neuropathy by application of extremity cooling: a prospective single-centre study with intrapatient comparison},
  journal = {Supportive Care in Cancer},
  year = {2024},
  volume = {32},
  number = {8},
  doi = {10.1007/s00520-024-08737-3}
}
Kostenlos starten →